Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Essex Bio-Technology Limited
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%
March 18, 2024
From
Essex Bio-Technology Limited
Via
ACN Newswire
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22%
August 16, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed
July 26, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
April 14, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
April 10, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
Essex Bio-Technology Announces 2022 Annual Financial Results
March 08, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
February 22, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
February 10, 2023
From
Essex Bio-Technology Limited
Via
ACN Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
